In the SNSF funded Sinergia project PHOR, photonuclear reactions will be investigated to produce radionuclides suitable for targeted tumor therapy, such as ²²⁵Ac.

This research is carried out in the groups of Prof. Dr. Andreas Türler (DCB), PD Dr. Saverio Braccini (LHEP) and Dr. Christian Kottler (METAS).

References:

• C. Kratochwil, F. Bruchertseifer, F. L. Giesel, M. Weis, F. A. Verburg, F. Mottaghy, K. Kopka, C. Apostolidis, U. Haberkorn, A. Morgenstern;
  "²²⁵Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer"
  J. Nucl. Med., 2016, 57(12), 1941-1944; doi:10.2967/jnumed.116.178673.
• Media Release of the University of Bern;
  "Fünf neue Sinergia-Projekte in Bern"
  Details.